Roche Molecular Systems Director of Business Development Salaries in Oakland, CA
The average Roche Molecular Systems Director of Business Development in Oakland, CA earns an estimated $229,805 annually, which includes an estimated base salary of $179,190 with a $50,615 bonus. Roche Molecular Systems' Director of Business Development compensation is $63,539 more than the US average for a Director of Business Development. Director of Business Development salaries at Roche Molecular Systems in Oakland, CA can range from $120,000 - $390,000.
In Oakland, CA, The Business Development Department at Roche Molecular Systems earns $1,232 more on average than the Design Department.
Last updated 2 years ago.
- $179,190
- avg. base
- $50,615
- avg. bonus
Director of Business Development Salaries at Roche Molecular Systems
In Oakland, CA, Directors of Business Development earn $3,416 more than Directors of Business Development.
Compensation at Roche Molecular Systems by Department
In Oakland, CA, The Business Development Department averages $1,232 more than the Design Department, and $3,492 less than the HR Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Roche Molecular Systems reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Roche Molecular Systems reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Roche Molecular Systems Rate Their Compensation
The majority of Directors of Business Development at Roche Molecular Systems believe they're compensated fairly. 100% of Directors of Business Development at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
